How we do business
Pulling back the curtain on the PBS
GSK and ViiV Healthcare aim to ‘pull back the curtain’ on the PBS with a video and report that explain how the Government assesses new medicines and vaccines.
Everyday health
Digital healthcare attitudes in Australia
How we do business
PharmAus 2017: Showcasing the health and economic benefits of innovation in medicines
The inaugural PharmAus showcase saw GSK and 19 other innovative pharmaceutical companies illustrate our industry’s investment and collaboration with Australia’s top research institutes, universities, biotechs and patients, to deliver the latest breakthroughs in treatment.
Innovation
Investing in our future
Access to healthcare
Access to healthcare
No 'silver bullet' to tackle this disease
Dr Sophie Biernaux, talks about GSK's commitment to fighting malaria.
Innovation
Bioelectronics
GSK's Bioelectronics R&D unit is pursuing a relatively new scientific field that could one day result in a new class of medicines that would not be pills or injections but miniaturised, implantable devices.
Access to healthcare
Giving babies a healthier start
Why are our scientists researching how to adapt an ingredient in mouthwash into a gel for newborn babies?
Our Community
Play-based learning for Australian kids
Every child has the right to a healthy, educated and safe future. Sadly, this is not the reality for all children. Some children drop out of school or have poor attendance because they don’t have the basic learning foundation to continue their education journey.
How we do business
Crowd sourcing new treatments for malaria
New medicines are urgently needed for diseases of the developing world and those medicines need to be affordable.
Innovation
Australian innovation pilot aims to reduce cost of vaccination in developing world
GSK has invested $7.7 million in a new pilot vaccine facility with the hope Australian manufacturing innovation could reduce cost of vaccination in developing world.
Access to healthcare
The fight against malaria
For the past 30 years, GSK scientists have been working with other organisations across the globe with the aim to develop what could be the world’s first malaria vaccine.
How we do business
Harnessing the electrical language of the body to treat disease
Bioelectronic medicine is a vision far from today’s medical practice. But we believe that one day, tiny devices, smaller than grains of rice, could be used to restore health in a range of chronic diseases centred on organs and biological functions.
Environment
Reducing our carbon footprint
Reducing our carbon footprint while addressing health access in neighbouring, less developed countries.
Our Community
Volunteering in Kenya
Through GSK’s PULSE Volunteer Partnership, our employees can use their professional skills to help create sustainable change for our non-profit partners and the communities they serve.
Our Community
NYSF - inspiring the next generation of scientists
With much of the world’s future innovation to come from science, technology, engineering and maths (STEM), it is very important that the innovators of tomorrow are supported and mentored.
Our Community
Keeping our Olympic athletes healthy and ready to compete in Rio
GSK is supplying the Australian Olympics Team with vaccines to protect them against everyday illnesses ahead of the games in Rio.
Everyday health
Every breathe you take: Alannah's story
Most of us take breathing for granted. It’s an automatic activity that we don’t need to think about. But imagine if every breath you took was a struggle; imagine waking up in the night wheezing and short of breath.
Our Community
Employees helping communities
Our people and the communities in which they operate are essential to our success. We focus on building their individual capabilities and aim to support and empower them to be the best they can be.
Everyday health
Keep moving - Jan's story
Jan was diagnosed with osteoarthritis after noticing aches and pains while swimming and carrying out my daily activities. Jan shares how this osteoarthritis has affected her life and how she manages the pain and inflammation brought about by this condition.
Access to healthcare
Increasing medicine access across the world's poorest nations
GSK expands graduated approach to patents and intellectual property to widen access to medicines in the world’s poorest countries.
Environment
Trusted partnership achieves supply chain improvements
When we received feedback that the number of eskies used for distribution of our vaccines was excessive we worked with our partner to find a solution.
Everyday health
Living with COPD: Peter's story
Can you imagine what it would feel like to take a breath when your lungs were already full of air? This is a feeling people with Chronic Obstructive Pulmonary Disease (COPD) may live with every day of their lives.
Access to healthcare
International collaboration seeks to make childbirth safer in developing countries
A global alliance led by GSK and Monash University promises to fast-track delivery of oxytocin to mothers in developing countries
Our Community
A comic book on vaccines
Immunisation rates among Australian children has risen significantly over the years. However, there remains a distinct disparity between children from Aboriginal and Torres Strait Islander communities and other Australians.
Our people
Karyn and Ahmed Trek for Kids
Two employees from Australia and New Zealand join 38 of their global colleagues to Trek for Kids in support of Save the Children in Ethiopia